Henry Schein | HSIC - Gross Profit On Sales

Stock Price
79.75
Daily Change
2.75 3.57%
Monthly
2.06%
Yearly
0.95%
Q1 Forecast
73.16

Henry Schein reported $1.03B in Gross Profit on Sales for its fiscal quarter ending in September of 2025.





Gross Profit On Sales Change Date
Agilent USD 990M 102M Sep/2025
Align Technology USD 683.59M 44.39M Dec/2025
Bruker USD 379.4M 21.5M Sep/2025
Cardinal Health USD 2.4B 78M Dec/2025
Charles River Laboratories USD 311.39M 6.77M Sep/2025
Cigna USD 56.45B 50.29B Sep/2025
Cooper Companies USD 650.8M 62.6M Sep/2025
CVS Health USD 13.81B 213M Sep/2025
Danaher USD 3.97B 443M Dec/2025
Dentsply International USD 441M 49M Sep/2025
Encompass Health USD 1.41B 786M Sep/2025
Henry Schein USD 1.03B 74M Sep/2025
Idexx Laboratories USD 658.11M 25.24M Dec/2025
IQVIA Holdings USD 1.12B 32M Dec/2025
Laboratory Of America USD 1.03B 21.1M Sep/2025
McKesson USD 3.68B 143M Dec/2025
Mettler Toledo International USD 675.44M 65.98M Dec/2025
Owens Minor USD 526.01M 53.75M Mar/2025
Quest Diagnostics USD 910M 6M Sep/2025
Revvity USD 374.6M 17.95M Sep/2025
Stryker USD 4.49B 633M Dec/2025
Tenet Healthcare USD 2.22B 22M Sep/2025
Thermo Fisher Scientific USD 4.64B 419M Dec/2025
Universal Health Services USD 2.01B 158.68M Sep/2025
Waters USD 459.99M 21.97M Sep/2025
Zimmer Biomet Holdings USD 1.27B 58.9M Sep/2025
Zoetis USD 1.72B 96M Sep/2025